Cyp40 is overexpressed in prostate cancer4 and certain T-cell lymphomas,5 suggesting that inhibition of complex formation with Hsp90 may also be therapeutically useful. The gene discussed is PPID; the disease is T-cell non-Hodgkin lymphoma.